Dr. Billett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1696 Eastchester Rd
2nd floor
Bronx, NY 10461Phone+1 718-405-8505
Summary
- Dr. Henny H. Billett is Director of the Thrombosis Program, Director of the adult Hemophilia Treatment Center and Director of Women's Blood Disorders at Montefiore Medical Center and Albert Einstein College of Medicine, Bronx NY. She received her medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 43 years. She specializes in thrombotic and bleeding disorders.
Education & Training
- London School of Hygiene and Tropical Medicine, University of LondonM.Sc, 1976
- Icahn School of Medicine at Mount SinaiClass of 1974
- University of PennsylvaniaB.A., Psychology, Cum Laude, 1970
Certifications & Licensure
- NY State Medical License 1975 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- The Best Doctors in New York New York Magazine, 2021-2022
- New York Super Doctors New York Times, 2020-2022
- Exceptional Women in Medicine Castle Connolly, 2020-2022
- Join now to see all
Clinical Trials
- Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) Start of enrollment: 2020 Feb 26
- Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD Start of enrollment: 2021 Nov 12
Publications & Presentations
PubMed
- 537 citationsA Pharmacogenetic versus a Clinical Algorithm for Warfarin DosingStephen E. Kimmel, Benjamin French, Scott E. Kasner, Julie A. Johnson, Jeffrey L. Anderson
The New England Journal of Medicine. 2013-12-11 - 513 citationsTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19., , , Ewan C Goligher, Charlotte A Bradbury
The New England Journal of Medicine. 2021-08-26 - 484 citationsTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19., , , Patrick R Lawler, Ewan C Goligher
The New England Journal of Medicine. 2021-08-26
Journal Articles
- Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisisManwani D, Chen G, Carullo V, Serban S, Olowokure O, Jang J, Huggins M, Cohen HW, Billett H, Atweh GF, Frenette PS, Shi PA, Am J Hematol, 1/1/2015
- HbF as an adverse predictor in pregnancy: a matter of F cell distribution?Billett HH, Blood, 1/11/2014
- Low Molecular Weight Heparin Bridging for Atrial Fibrillation: Is VTE Thromboprophyaxis the Major Benefit?Billett HH, Scorziello BA, Giannattasio ER, Cohen HW, J Thromb Thrombolys, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospe...Henny Heisler H. Billett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Direct Oral Anticoagulants for Prevention of Recurrent Thrombosis in Myeloproliferative NeoplasmsHenny H. Billett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy and Safety of Direct Oral Factor Xa Inhibitors in Patients after Bariatric SurgeryHenny Heisler H. Billett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Neutrophil Extracellular Traps (NETs) Are a Subset of Smudge Cells Identifiable By Peripheral Smear Autoanalyzers61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Wide Variation in Duration of Anticoagulation after Catheter-Related Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- VTE (Part 2): Therapy and Duration1/1/2016
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: